• Eloro Resources’ Executive VP of Exploration, Bill Pearson was recently featured on BTV
• During the interview, Pearson revealed his optimism surrounding the company’s ongoing exploratory works within Bolivia’s Iska Iska project
• Eloro Resources have now drilled over 70,000 meters cumulatively across 102 holes whilst employing five drills
• The company is now working towards publishing its maiden mineral resource estimation report alongside its NI 43-101

Two years ago, Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, was taking its initial steps towards realizing its maiden drilling campaign within in its Iska Iska project located in southern Bolivia. Today, the company believes that they may have, quite literally, hit pay dirt. Eloro Resources Executive VP of Exploration, Bill Pearson was recently the subject of a wide-ranging interview on Business TV (“BTV”); during the question and answer session, Pearson expressed his optimism on the company’s prospects following its recent exploratory work whilst simultaneously suggesting that the possibility that Eloro could potentially uncover a world class, multi-million ounce deposit of silver and tin within the Iska Iska project may not be far off from the realm of possibility (https://ibn.fm/FP5ua). Over the past two years, Eloro Resources have drilled upwards of 102 holes and over 70,000 cumulative meters across a tract of land measuring eight square kilometres; remarkably according to Pearson, with every single drill hole boasting multiple intersections, the company had yet to come up dry on any of its initial probes. Eloro will now look to formulate its maiden resource estimate, with the upcoming publication of its initial NI 43-101 report providing the market with further scientific and technical information about the economic viability of its project (https://ibn.fm/FtH9r). “There’s going to be a lot of good news coming out through the fall and culminating in the MRE (mineral resource estimation)”, Pearson stated. The commercial usage of tin and silver have skyrocketed in recent years, with both metals playing essential roles within the ongoing global effort towards decarbonisation. Whilst silver has long been prized for over 5,000 years as a store of value, the precious metal today arguably holds even more value in its scientific applications. As a result of silver’s superior thermal conductivity, a paste containing silver has rapidly transformed into a critical component within the construction of both, solar photovoltaic cells and crystalline silicon photovoltaic cells, alike. With the average solar panel making use of approximately 20 grams of silver, solar panels now account for over 8% of annual silver demand – a figure which is set to grow at over 9% per annum for the foreseeable future (https://ibn.fm/BC24M). Elsewhere, tin has rapidly emerged as a crucial cog within the process of soldering electronics such as semiconductors, solar panels and batteries. The continued rollout of 5G telecom networks and development of the Internet of Things (“IoT”) along with the consequent increase in demand for tin soldering in new telecom equipment are expected to drive further spikes in the base metal’s price, with soldering alone expected to account for 49% of the metal’s end-demand in the near term. “There is no electrical device on the plant that functions without tin, so our expectation is that tin usage will skyrocket”, explained Pearson. “[Meanwhile] silver is essential for the production of solar panels. The rate of solar panels production is skyrocketing, so that rate of usage is going to go up, and up”, he elaborated. With critical mineral demand on the upswing and the company on the verge of a major discovery, management anticipate that Eloro are on the cusp of something big. “There is a lot of upside in this story as we move forward with our intial MRE, and ultimately that will lead to looking at possible developments down the road. There will be a major mine in Iska Iska one day and it probably won’t be in such a distant future,” Pearson concluded. For more information, visit the company’s website at www.EloroResources.com. NOTE TO INVESTORS: The latest news and updates relating to ELRRF are available in the company’s newsroom at https://ibn.fm/ELRRF

• Small to medium-sized businesses (“SMBs”) face potentially prohibitive costs when it comes to hiring full-time cybersecurity experts
• Despite the costs concern, the need is growing, as malicious computer experts often turn to SMBs and organizations as easy prey because of the smaller companies’ lack of experience, budget, and infrastructure necessary to ward off computer network invasions
• A San Diego school district recently reported its employees’ personal data was compromised in a cyberattack, and a Los Angeles school district reported it received a ransom demand after its computer files were seized in September and then published on the dark web
• SideChannel Inc. is helping SMBs to bridge the cybersecurity cost divide by offering virtual chief information security officers (“vCISOs”) as a contracted service that is more affordable than an in-house employee

When the San Diego Unified School District acknowledged recently that the personal information of many current and former employees was taken by unknown actors in a cybersecurity incident, it established that potentially malicious individuals have turned to public school systems in the latest reports of computer breaches. NBC affiliate KNSD reported that prior to the incident in San Diego, a number of cybersecurity incidents involving schools and health care systems had been reported in California, including an attack on The Los Angeles Unified School District in September that locked up the district’s files and demanded a ransom payment, before thousands of files were stolen and then leaked on the dark web (https://nnw.fm/bcLpp). (https://ibn.fm/C0lZa). Businesses and public entities may represent a wide variety of organizational sizes and purposes, but they all share the common need for technological security against invasive threats from across the Internet. A report by cybersecurity student Matthew McKenzie on Tripwire, Inc.’s web forum indicates that small to medium-sized businesses have become malicious computer experts’ ideal targets because the SMBs tend to lack the experience, budget and infrastructure necessary to ward off computer network invasions. Small businesses with less than 100 employees will experience 350 percent more social engineering attacks than larger enterprises, and 60 percent of small companies go out of business within six months of falling victim to a data breach or cyber-attack, the report states (https://nnw.fm/FoqBx). (https://ibn.fm/SwtK5). Virtual chief information security officer experts at SideChannel (OTCQB: SDCH) are dedicated to matching vCISOs with SMBs to help even the playing field in terms of Internet security in the broader marketplace. “Small and mid-market companies are incredibly challenged by a lack of cost-effective means to comfortably and securely handle network management,” SideChannel Executive Vice President David Chasteen stated in September when the company rolled out its Enclave microsegmentation software platform as a solution for SMB cybersecurity needs (https://nnw.fm/GOpaf). (https://ibn.fm/EqZMw). “These companies want to focus on their business and their customers; not worry about who is accessing what server, or if the encryption installed is sufficient. We built Enclave to provide these companies an affordable and effective segmentation solution that significantly reduces the amount of effort required, through a simple and intuitive interface.” In-house CISOs currently earn an average salary of $200,000 annually in the United States, according to a Security Boulevard report on how virtual CISOs are changing cybersecurity availability for SMBs. “Hiring a full-time security expert can be expensive and also create inflexibility. The hiring company is wedded to its security expert, in essence. Locating a new person is time-consuming and expensive. Thus, the cost of hiring the wrong CISO can be prohibitive,” the report states (https://nnw.fm/hutQp). (https://ibn.fm/s4H5N). “The virtual CISO model is helping small companies overcome this hurdle. Small businesses can hire and evaluate vCISOs in a real-world environment before deciding to commit to their services over the long term. The contractual nature of the position makes it easy for firms to replace talent, should they be inadequate.” For more information, visit the company’s website at www.SideChannel.com. NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://nnw.fm/SDCH https://ibn.fm/SDCH

• Cannabis grower and brand builder Flora Growth is a rapidly growing international supplier and supply chain developer aiming to distinguish itself in a highly competitive market
• Following on a 604 percent YOY revenue increase for the first half of the year, Flora continues pursuing strategic acquisitions such as its recent all-stock deal for multi-national operator Franchise Global Health
• Flora also anticipates expanding its production facilities, adding a fourth by the end of this year that will provide the company with its first pharmaceutical formula operation for the Colombian wellness market
• The Franchise Global Health agreement is expected to give Flora a strong presence in Germany and an introduction to Europe, adding to its export pipeline to Switzerland, the Czech Republic and the United States from Colombia

Legal cannabis has become the the sixth-largest cash crop in the United States after corn, soybeans, hay, wheat and cotton (https://ibn.fm/64tSI), and voters continue to address the potentials of an expanding market for recreational marijuana (https://ibn.fm/1Z86I). Non-recreational medicinal cannabis has been legalized in 37 states and continues to fuel a multi-billion dollar industry (https://ibn.fm/E1Qcb), which is only a portion of the global market that supplies the 80 percent of the world’s population using cannabis or hemp for medical treatments. For now, international annual growth rates are more robust than the projected growth rates in the United States, according to Kiplinger (https://ibn.fm/Pwe9t). Cannabis cultivator and global distributor Flora Growth (NASDAQ: FLGC) is a rapidly growing house of brands building customer bases and distribution channels across international lines as it aims to distinguish itself within a highly competitive arena. Much of Flora Growth’s strength lies in its licensed cultivation, extraction, and isolation facility located in northern Colombia’s fertile climate, where an experienced labor force is helping the nation emerge from decades of drug war illicit trade into a recognized and regulated market. From its 247 acres of growing fields, the company’s harvests move into a production pipeline that includes a flower and derivatives production lab situated with the cultivation camp, as well as a topical, capsules and dietary supplements lab in Colombia’s capital and a third lab in the United States, where CBD ingestible, tinctures and gummies are made. A fourth state-of-the-art lab being built in Colombia’s capital is being designed to formulate custom and proprietary pharmaceuticals that will be sold and used in Colombia. The life sciences lab is expected to open by the end of this year with eight registered pharmaceutical grade formulas that target specific ailments such as insomnia, epilepsy, and anxiety (https://ibn.fm/kUqZO). “At Flora, we believe that cannabis will dramatically improve the wellbeing of consumers around the globe and that it will become an international trade. Our company exists today to capitalize on that opportunity,” CEO Luis Merchan stated last month in an interview about its most recent acquisition to help fuel its global ambitions — an all-stock deal for multi-national operator Franchise Global Health (https://ibn.fm/JgfT3). The Franchise Global Health (“FGH”) acquisition is expected to give Flora an in-road to Europe through Germany, where FGH helped pioneer the European cannabis market and where 75 to 80 percent of European sales take place. FGH’s German businesses operate primarily in the export pharmaceutical and medical cannabis import and distribution markets, servicing 1,200 pharmacies in Germany, according to a company news release (https://ibn.fm/UBGQA). Notably, while Flora’s operation provides THC and CBD flower and derivatives to international markets, the company only produces CBD products within the United States because its NASDAQ listing prevents it from participating in the THC (traditional tetrahydrocannabinol cannabis) market domestically. For more information, visit the company’s website at www.FloraGrowth.com. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

• Real estate market watchers have been encouraged by recent trends in inflationary policy and lending policy analysis
• The mid-December Consumer Price Index report and the subsequent Federal Reserve funds rate decision fell in line with expectations that inflation may have passed its peak and is beginning to decline
• Real estate lenders expect mortgage rates to trend lower as a result of the policy news
• Miami-based REZYFi Inc., a mortgage lender working with traditional loans and non-traditional market sectors such as the cannabis industry, has been preparing to meet a very fast-growing residential mortgage origination opportunity
• REZYFi is working toward an IPO, having built a network of independent brokers and proprietary technology to service home owners and corporate clients with proprietary automated/machine learning technology

Housing market watchers are celebrating the Federal Reserve’s announcement Dec. 14 that it was going to raise the federal funds rate for the seventh time this year to curb inflation, recognizing that the announcement was in line with predictions that cooling inflation trends could lead to the start of a trend by policymakers to lower the amount of rate increases and thereby begin lowering mortgage rates. After several 75 base points increases this year, December’s 50 base points decision and the companion reports of inflation-limiting successes in the Consumer Price Index (“CPI”) (https://ibn.fm/Wd4Ma) have led investors to speculate that central bank policymakers would pursue a less aggressive policy path in 2023. As a result, the Mortgage Bankers Association (“MBA”) is predicting that 30-year fixed mortgage rates expected to end this year at 6.7 percent will drop to 5.2 percent next year, according to a HousingWire report (https://ibn.fm/8fur7). Overall mortgage application volume rose 3.2 percent during the week before the coupling of the CPI report and the Fed’s rate announcement, with applications to buy a new home rising 4 percent, and the potential for a positive rate trend is driving hopes that further housing market gains will take place next year. “The ongoing moderation in home-price growth, along with further declines in mortgage rates, may encourage more buyers to return to the market in the coming months,” Joel Kan, an MBA economist, stated (https://ibn.fm/zVq9r). Similar reports of potentially passing peak inflation in Europe cautiously bolster the market expectations on a global level (https://ibn.fm/sh6PS). Real estate-oriented mortgage loan origination company REZYFi has spent the past five years building its strategy to meet a very fast-growing residential mortgage origination opportunity, further encouraged by the early pandemic home sales boom and the now-developing optimism for future market improvements. REZYFi has developed an extensive network of independent mortgage-related brokers and licensed loan officers while investing heavily in proprietary automated/machine learning technology to shorten loan processing timeframes and reduce inefficiencies related to loan processing, underwriting and servicing. The company also is focusing on non-traditional lending markets such as licensed and permitted cannabis companies, as well as owners of real estate who lease to cannabis companies. REZYFi is building toward a planned public IPO launch for its operation, and with its 100 percent-owned subsidiaries REZYFi Lending and ResMac Inc. has established licensing in 36 states with plans to expand across the entire United States. For more information, visit the company’s website at www.REZYFi.com. NOTE TO INVESTORS: The latest news and updates relating to REZYFi are available in the company’s newsroom at https://ibn.fm/REZY

• With high-profile hacks abounding in 2022, Gartner forecasts that by 2025, 80% of enterprises will have adopted a strategy to unify web, cloud services, and private application access from a single vendor’s SSE platform
• Data443 Risk Mitigation offers a comprehensive and diverse software-as-a-service portfolio for data protection that is trusted by some of the world’s biggest companies
• During the first nine months of 2022, Data443 reported $2.3 million in revenue and $2.7 million in deferred revenue as it transitions customers from a one-time payment model into a recurring revenue model

As 2022 winds down, another year of lessons about data protection is in the books, alongside a year’s worth of notable breaches that made cybercriminals rich while costing economies and businesses billions of dollars. Teenage hacker group Lapsus bursts on the scene, hacking some of the world’s biggest companies, including Microsoft and Samsung. Vice Society hacked the U.S.’s second-biggest school district. Crypto video game company Axie Infinity was pillaged by cybercriminals to the tune of $620 million. Even hackers weren’t safe. Nefarious ransomware group Conti was penetrated by Ukrainian “hacktivists” that released internal content showing how they conduct their criminal enterprise. 2023 will likely be distinguished by a growing number of approaches using consolidated cybersecurity architecture and multi-layer approaches to protect against criminals who are notoriously adept at prying their way through any weakness, like a sentinel in the Matrix. Through strategic acquisitions, Data443 Risk Mitigation (OTC: ATDS) is uniquely positioned to benefit from increased demand for data protection with its portfolio of software solutions, allowing a unified approach to data governance and security. Data443, whose ATDS stock ticker is an acronym for “All Things Data Security(TM),” recently published an Investor Presentation with the SEC, illustrating their efforts to provide software and services to enable secure data across devices and databases, at rest and in transit, locally, on a network, or in the cloud. With over 10,000 customers in over 100 countries, Data443 provides a modern approach to data governance and security by identifying and protecting all sensitive data regardless of location, platform, or format. The Research Triangle Park, North Carolina-based company’s framework helps customers prioritize risk, identify security gaps, and implement effective data protection and privacy management strategies. Data443 can trumpet an expansive list of opportunities for businesses to connect with their security solutions. The possible connectors range from Act CRM to Zuora and include popular platforms, such as Slack, SharePoint, WordPress, PayPal, Microsoft, Google, Amazon, eBay, and hundreds more. In all cases, Data443 solutions are designed for the same purpose: protecting all IT attack surfaces to minimize ransomware threats, data hijacking, and system hacking. In its recent Gartner(R) report, “Predicts 2022: Consolidated Security Platforms Are the Future,” the research firm makes several key findings in the fast-changing threat landscape, including expectations that companies will invest in integrated security approaches. More precisely, Gartner forecasts that by 2025, 8 out of 10 enterprises will have adopted a strategy to unify web, cloud services, and private application access from a single vendor’s SSE (security service edge) platform. That plays right into Data443’s wheelhouse as a provider of à la carte options. The comprehensive offerings can do everything from locating data anywhere, moving it to where it should be to protect it, securely archiving it for a specified time, or even compliantly and permanently destroying it as requested. The diverse offerings appeal to an array of customers for different reasons, such as global fintech (secure data protection, transport, distribution); mid-market (archiving, ransomware protection, content viewing, and distribution); and small-to-medium businesses (plugins and website apps, freemium and badges, privacy compliance). To the SMB point, Data443 has created awareness for its products through a “freemium” marketing strategy that provides plugins to over 200,000 WordPress users. Elsewhere, its Data443® Antivirus Protection Manager earned the prestigious VB100 Certification from Virus Bulletin earlier this year. Employing a growth-by-acquisition strategy along with its organic ways, Data443 in January completed the acquisition of certain assets from Centurion Technologies, namely its ransomware protection and device recovery technologies, along with ancillary assets. The purchase brought Data443(R) the leading technical component to comply with newly established requirements from the Cybersecurity & Infrastructure Security Agency (“CISA”), as mandated by the Biden Administration. The acquisition provides substantial cross-sell opportunities considering Centurion’s products are used worldwide with over three million licenses deployed. For obvious security reasons, Data443 doesn’t disclose the names of most of its clients, but it is clear that some major players trust Data443. Examples from this year include a five-and-a-half-year contract with a “Fortune 500 Fintech Member,” a multi-year contract with a “leading financial services organization in Puerto Rico,” a multi-year contract with a “major US energy provider with over 30,000 employees,” and, only a few weeks ago, a $350,000 contract addition to an existing agreement with “a leading global investment bank headquartered in New York City with over $2 trillion in assets.” The contract relates to additional licensing for the Data443 Data Placement Manager(TM) product, an HPE NonStop server-based application for secure managed file transfer that enables customers to schedule, route, format, and securely transfer business-critical data over both public and private networks. This client has been using Data443 for years, relying upon its data transfer technology to send and receive tens of thousands of files daily, which are the core of the intra-banking relationship for most banks worldwide. In its quarterly update in November, Data443 said that it had retained 99% of its clients this year. Revenue for the year through Q3 was $2.28 million, down some from the previous year as customers took advantage of multi-year contract incentives in 2021, while Data443 transitioned from a one-time payment model to annual maintenance and subscription models. Deferred revenues through September stood at $2.65 million, up more than $1.0 million from the same period in 2021. Observed, “Our results for the third quarter came in largely as expected, and we continue to see high revenue customer retention amidst extremely challenging economic conditions. We continue to focus on realigning our current customer relationships to a subscription and monthly recurring revenue model. While this has affected straight-line revenue growth year-over-year, our increased and growing deferred revenues, diverse revenue base, and increased analyst attention demonstrate our business’s strong momentum.” “Looking ahead, we anticipate ending 2022 on a high note as we continue to work and deliver on renewals and net new opportunities with customers,” said Data443 CEO & Founder Jason Remillard in a statement on the company’s progress this year. “We continue to expand the adoption of our product sets in some of the world’s largest organizations, supporting business-critical data in flight and at rest, in the cloud or on-premises. I am confident that Data443 is well positioned to make the most of the substantial market opportunity before us, continuing our mission: To organize the world’s information by identifying and protecting all sensitive data regardless of location, platform, or format,” he concluded. For more information, visit the company’s website at www.Data443.com. NOTE TO INVESTORS: The latest news and updates relating to ATDS are available in the company’s newsroom at https://ibn.fm/ATDS

• EVGIF announced 80% completion of GrowTEC expansion, finalizing construction of injection infrastructure to connect system to local RNG pipeline network
• GrowTEC RNG production expected end of 2022, planned capacity of approximately 140,000 GJ/year
• Released Q3-2022 financial results, highlights included YOY revenue increase to C$2.0 million, cash and cash equivalents of C$12.8 million
• Key milestones achieved included signed term sheet for long-term RNG offtake agreement, signed term sheet for C$31 million senior term loan, commencement of Fraser Valley Biogas RNG Expansion Project

EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF), a renewable energy company that is developing Canada’s renewable natural gas (“RNG”) infrastructure platform, recently announced that its GrowTEC expansion is 80% complete with production planned by the end of 2022 (https://ibn.fm/pX5t3). GrowTEC is an operating biogas facility that converts organic waste to soil amendments and clean energy. EVGIF acquired a 67% interest and assumed operations of the biogas facility earlier this year. The company recently completed the acquisition and is currently finalizing the construction of the injection infrastructure that connects the system to the local pipeline network. Production is expected to commence by the end of 2022 with a planned capacity of approximately 140,000 GJ/year of RNG (https://ibn.fm/5kJTe). “We are thrilled with the pace at which our team has delivered this project,” said EverGen CEO Chase Edgelow. “Phase 1 is tracking ahead of schedule and once commissioned, the project will further contribute to and strengthen our positive cash flow position.” EverGen is dedicated to helping meet Canada’s sustainability targets by building RNG infrastructure across the country. The company aims to own over 20 facilities across Canada within five years, an investment made possible through long-term contracted revenue agreements with Canada’s utility companies. Concurrently, the Canadian Gas Association aims to blend natural gas with a target of 5% RNG or hydrogen by 2025, and 10% by 2030 (https://ibn.fm/5PpfT). According to the agency, the move will reduce greenhouse gas emissions by 24 megatons – equivalent to removing 5.2 million passenger cars from the road. EVGIF recently provided project status updates in the company’s Q3-2022 financial results report for the three- and nine-month periods ended September 30, 2022 (https://ibn.fm/DEAi2). Highlights included revenues of C$2.0 million – an increase from C$1.9 million in Q3-2021, and cash and cash equivalents of C$12.8 million. Key milestones achieved included a signed term sheet for a long-term RNG offtake agreement at Fraser Valley Biogas, the completed acquisition of GrowTEC, a signed term sheet for a C$31 million Senior Term Loan, and the commencement of the Fraser Valley Biogas RNG Expansion Project. Based in Vancouver, British Columbia, EverGen is an established independent renewable energy producer committed to developing Canada’s RNG infrastructure. With projects located across the country, the company is emerging as a leader committed to powering a sustainable, net-zero future based on renewable energy sources. For more information, visit the company’s website at www.EverGenInfra.com. NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

• BEAT continues impressive march forward in developing a suite of products designed to detect heart attacks anytime, anywhere
• Inventions protected by patent enable proprietary 3D vector ECG technology to be built into a smartwatch
• Projections for global smartwatch and wearables medical-device markets show consistent upward growth

In a world where an estimated 202.6 million people use smartwatches (https://ibn.fm/zb66P), the ability to harness the power of smartwatches to help people live healthier lives can make a profound difference. That’s exactly what HeartBeam (NASDAQ: BEAT), a cardiac technology company with a track record for innovation and cutting-edge technology, hopes to do with its newest patent.

The company announced on November 16, 2022, that it was granted a patent for its 12-lead electrocardiogram (“ECG”) smartwatch-based monitor design to identify heart attacks and complex cardiac arrhythmias (https://ibn.fm/DFeQC).

“The breakthrough inventions protected by this patent enable our proprietary 3D ECG technology to be built into a smartwatch, eliminating the need for a dedicated ECG device while offering a 12-lead ECG capability enabling heart attack and complex arrhythmia detection,” said HeartBeam CEO and founder Branislav Vajdic, PhD. “This patent may prove to be one of the most valuable patents in our rich and growing patent portfolio and, together with our 12-lead ECG patch patent, I believe, will have a disruptive effect on these existing multibillion-dollar fast-growing markets.”

Projections for the global smartwatch market for the next several years show consistent upward growth, boding well for HeartBeam. “Data Bridge Market Research analyses that the smartwatch market was valued at $33,081.86 million in 2022 and is expected to reach $64,480.18 million by 2030, registering a CAGR of 8.70% during the forecast period of 2023 to 2030,” reported a recent PR Newswire press release (https://ibn.fm/cWWmX).

In addition, HeartBeam pointed out that the global wearables medical-device market is also expected to see billion-dollar growth, estimated to reach $196 billion by 2030. This space “encompasses a wide variety of capabilities, including diagnostic monitoring such as heart rate and some cardiac arrhythmias, blood pressure, glucose, respiratory, and sleep activity, among others,” the company stated. “Currently available wearables are not capable of providing a 12-lead ECG for heart attack detection, complex arrhythmia monitoring or other cardiac disorders. With cutting-edge, 12-lead ECG based on 3D vector ECG technology built into a smartwatch, HeartBeam’s latest patent further expands on the company’s anytime, anywhere capabilities.”

HeartBeam has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere. By applying a suite of proprietary algorithms to simplify vector electrocardiography, the HeartBeam platform enables patients and their clinicians to determine if symptoms are due to a heart attack, quickly and easily, so care can be expedited, if required.

HeartBeam has two patented products in development: HeartBeam AIMI(TM), software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECGs to identify a heart attack more accurately, and HeartBeam AIMIGo(TM), the only credit-card-sized, 12-lead output ECG device coupled with a smartphone app and cloud-based diagnostic software system to facilitate remote heart attack detection.

The company noted that, while it is currently focused on the development of these two systems, it is also committed to continue advancing the full potential of cutting-edge, 12-lead 3D vector ECG technology. That commitment is demonstrated by recently issued and allowed patents that appear to have the potential for significant market impacts, including this 12-lead, ECG, smartwatch-based monitor design. HeartBeam AIMI and HeartBeam AIMIGo have not yet been cleared by the US Food and Drug Administration for marketing in the USA or other geographies.

For more information, visit the company’s website at www.HeartBeam.com.

NOTE TO INVESTORS: The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT

• Jupiter Wellness’s product pipeline addresses a range of underserved conditions, including hair loss, eczema, burns, and sexual wellness
• The company’s revenue is generated through OTC and consumer product sales, contract research agreements, and licensing royalties
• Jupiter Wellness recently announced that it has been approved to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs

Jupiter Wellness (NASDAQ: JUPW) is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company has a robust and growing portfolio of granted and pending patents to protect its proprietary products. Jupiter Wellness’s product pipeline, backed by clinical research to ensure efficacy, addresses a range of underserved conditions. The company’s revenue is generated through a combination of OTC and consumer product sales, contract research agreements, and licensing royalties. Jupiter Wellness was formed in 2018 and is headquartered in Jupiter, Florida. Products with Purpose Jupiter Wellness’s product pipeline currently targets a variety of indications with underserved needs. These include:

• Hair Loss – Jupiter Wellness’s Minoxidil Booster is a topical treatment that’s been clinically shown to increase the enzymes needed for minoxidil to work by up to 7x over a two-week period. The product has been licensed to Taisho, a $2.6 billion revenue company and Japan’s leading seller of minoxidil products, which expects to launch it commercially in 2023. The product is licensed to India-based Cosmofix Technovation Pvt. Ltd. and Sanpellegrino Cosmetics, and additional licensing opportunities are being pursued.
• Psoriasis & Vitiligo – Photocil safely and effectively permits phototherapy treatments at home by blocking harmful radiation and permitting the passage of therapeutic UV radiation. The product has been licensed abroad and is currently being launched commercially in India by Eris Oaknet Healthcare and Cosmofix Technovation under the brand name PhotoFirst. The product is also available in the U.S., and the company is working to find new partners in dermatology for expanded distribution.
• Jellyfish Protection Sunscreen – NoStingz is a topical protection from jellyfish, sea lice, and UVA/UVB rays. It provides an effective barrier against the stinging mechanism of jellyfish cnidocytes, preventing the delivery of venom to the victim. NoStingz is currently available online through Amazon and Walmart, as well as in select stores.
• Eczema – JW-100 is a pre-revenue topical treatment for atopic dermatitis (eczema). In prior studies, JW-100 cleared or reduced eczema symptoms following 2 weeks of use. Results suggest that JW-100 may potentially prove superior to existing prescription drugs. It is currently being evaluated in a Phase 3, double-blind, placebo-controlled multicenter trial.
• Burns – JW-300 is a pre-revenue topical treatment for first-degree burns and sun exposure. In prior studies, JW-300 was shown to significantly lower the incidence of burns in patients exposed to UV radiation. It is currently being evaluated for sale as an “after sun” consumer product.
• Cold Sores – JW-400 is a pre-revenue topical treatment of herpes labialis (cold sores). A phase 1, double-blind, placebo-controlled investigational study is currently being planned for JW-400.
• Sexual Wellness – JW-500 is a pre-revenue topical treatment for female libido loss. In clinical studies, the topical formulation improved nipple sensitivity and alleviated associated sexual problems. Jupiter Wellness plans to file for a pre-IND meeting with the U.S. FDA within the next 12 months and intends to seek Orphan Drug Designation.
• COVID-19-Induced Tinnitus – JW-600 is currently being evaluated in a triple-blind clinical study. Up to 15% of patients recovering from COVID-19 have experienced post-acute COVID-19-induced tinnitus

Management Team Brian John is the CEO of Jupiter Wellness. For the past 20 years, he has been an investor and advisor to companies around the globe. He is the founder of a successful financial consulting firm specializing in helping emerging growth companies and has worked with hundreds of companies in dozens of countries over the last 25 years. Mr. John also serves on the board of directors of The Learning Center at the Els Center of Excellence – a school for children with autism in Jupiter, Florida. Doug McKinnon is the CFO of Jupiter Wellness. His 35+ year professional career includes financial, advisory, and operational experience across a broad spectrum of industry sectors, including oil and gas, technology, cannabis, and communications. He has served in C-Level positions in both private and public sectors, including as chairman and CEO of an American-stock-exchange-traded company; as VP – Chief Administrative Officer of a $12-billion-market-cap Nasdaq-traded company; as CFO of several publicly-held U.S., Canadian and Australian companies; and as CEO/CFO of various other private enterprises. Dr. Glynn Wilson is the Chief Scientific Officer of Jupiter Wellness. He brings to the company an extensive background of success in corporate management and product development with tenures in both multinational and start-up biotech organizations. He was formerly Head of Drug Delivery at SmithKline Beecham Pharmaceuticals; Research Area Head in Advanced Drug Delivery at Ciba-Geigy Pharmaceuticals; and Founder, CEO, and Chairman of TapImmune Inc., which became Marker Therapeutics through a merger. At TapImmune, he licensed cancer vaccine technology platforms and established the clinical pipeline. For more information, visit the company’s website at www.JupiterWellness.com. NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW

• Ludlow Research ups price target for MetAlert, leading developer of location-sensitive health monitoring devices and wearable technology products, anticipating target between $1 and $1.25 per share
• MetAlert announced the elimination of all its toxic convertible notes from its balance sheet, which now provides increased stability to its public float
• The company also shared improved guidance to its NFC operations while also announcing the launch of new medical devices geared toward the geriatric and autism healthcare markets
• Q4 2022 also saw the influx of new chips, which will significantly increase production of the company’s SmartSole units in early 2023, ramp up production and fulfilling of backorders currently in place, and increase revenues in the coming months
• These moves present a unique opportunity for investors to capitalize on the impending price surges

New York based equity research firm Ludlow Research, has updated its research opinion for MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products. MetAlert just marked a successful fourth quarter of the 2022 financial year (“Q4 2022”), with the elimination of all toxic convertible notes (“TCN”) from its balance sheet. In what promises increased opportunities for its investors, MetAlert also shared improved guidance to their Near Field Communication (“NFC”) operations while also announcing the launch of new medical devices geared toward the geriatric and autism healthcare markets (https://ibn.fm/vAwkE). TCN, also referred to as toxic debt, often converts at deep discounts to market price, ultimately contributing to shareholder dilution and price instability for small issuers. As a result, it can be detrimental to a company’s financial health. With MetAlert having eliminated all of its toxic debt, its management is confident that the company is in a position now to provide increased stability for its public float. This brings to a close a successful quarter for MetAlert, which also saw the launch of new medical devices such as RoomMate. In addition, the influx of new chips in this period, its management noted, would significantly increase production of its SmartSole units in early 2023, a move that will be integral in ramping-up production and fulfilling backorders currently in place. This move will also increase the company’s revenues in the coming months (https://ibn.fm/lHBg5). Extinguishing all toxic debt was an ambitious move for MetAlert that has since paid off for shareholders. This, coupled with improved guidance operations and the launch of new medical devices, presents a unique opportunity for investors to capitalize on the impending price surges. In addition, the demand for its line of innovative healthcare products, along with the growing size of the worldwide population that needs its technologies, gives MetAlert a significant competitive edge and a unique value proposition that is attractive to investors. As a result, Ludlow Research has placed the new price target for the company’s shares at between $1 and $1.25 per share. For more information, visit the company’s website at www.MetAlert.com. NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT

• Clean energy solutions innovator Correlate Infrastructure Partners Inc. is a company focused on helping businesses that develop and rent out commercial building properties to adopt smart energy use and reduce harmful climate impacts
• Smart energy programs have gained traction during the past year as the federal government has enacted laws funding climate-friendly initiatives on a massive scale
• Investors in public companies have shown a growing interest in supporting corporations with strong environmental, social, and governance (“ESG”) profiles as a measure of their efforts to pursue environmentally sustainable production
• CIPI helps corporate clients analyze their energy use practices, assess areas of possible ESG improvement, and find ways to realize cost advantages from making changes

During the past year, the current administration has passed legislation funding a wide-ranging series of climate-improving environmental measures, and utilities innovators such as distributed energy solutions company Correlate Infrastructure Partners (OTCQB: CIPI) have positioned themselves to take maximum advantage. The transformative effort to overhaul the nation’s economy and address climate change during 2021 and 2022 included the Infrastructure Investment and Jobs Act (“IIJA”), which has been rebranded as the Bipartisan Infrastructure Deal (https://ibn.fm/mHmzH), and led to passage of the landmark Inflation Reduction Act of 2022 (“IRA”) (https://ibn.fm/ngkhh). The U.S. Department of Energy (“DOE”) recently announced that it has begun taking applications for a grants program that will provide an initial $80 million of the $500 million program to public schools across the country to help them perform energy improvements, focusing particular attention on rural and low-income urban districts. “School facilities are the second-largest sector of public infrastructure spending according to the American Society of Civil Engineers, yet school buildings are consistently reported as aging, unhealthy and inefficient,” the DOE’s news release states (https://ibn.fm/jt3w8). “The Renew America’s Schools program … will help create healthier learning environments, lower utility costs and redirect funds to support students and teachers.” The DOE also announced this month that it intends to invest up to $72 million from the Bipartisan Infrastructure law to expand a training program for workforce development to support energy efficiency and emissions reductions in commercial and institutional buildings (https://ibn.fm/0f6cn). The Bipartisan Infrastructure Deal also will invest more than $7 billion in the supply chain for batteries essential to providing affordable clean energy, $1.5 billion for clean hydrogen manufacturing, and $750 million to support advanced energy technology manufacturing projects in coal communities “The Bipartisan Infrastructure Deal will turbo-charge clean energy deployment by funding several highly effective state and local programs that will spur projects that increase access to energy efficiency to save money for American families, businesses and communities, help achieve our clean energy goals and accelerate job growth,” the DOE stated last month (https://ibn.fm/B2q3R). Correlate Infrastructure Partners has established a platform for helping the commercial real estate industry (companies that develop and rent out commercial building properties) succeed at acquiring solar, cogeneration, energy storage, and electric vehicle infrastructure. Such climate-friendly measures have gained gravitas with corporations as investors have shown increasing interest in supporting businesses with good environmental, social and governance (“ESG”) profiles, pouring $69.2 billion into ESG-weighted funds last year (https://ibn.fm/fk7kn), despite political challenges (https://ibn.fm/CLNow). CIPI’s distributed energy solutions provide clients with current energy use analysis, recommendations for optimization, and advisement on access to financial resources that will ultimately help the clients reduce their costs as they make climate-friendly improvements. For more information, visit the company’s website at www.CorrelateInfra.com, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.CorrelateInfra.com/our-process
• Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.CorrelateInfra.com/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI